Allergy and Immunology, Allergy · Fair Lawn, NJ
NPI
1235128497
Since 2005
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
23-00 Route 208 South
Fair Lawn, NJ, 07410
Phone (201) 794-7400
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
1,767 services
Medicare patients, 2024
91
Average age 71
Drug cost, 2024
$5.3M
467 prescriptions
Company payments, 2025
$48K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jay M Kashkin was code 99214 (office e&m - established), 48 times for 41 patients. In total Jay M Kashkin billed 1,767 services in 16 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 48 | 41 | $103.72 | $4,979 |
| 99204 Office E&M - New | Office | 30 | 30 | $127.77 | $3,833 |
| 99213 Office E&M - Established | Office | 13 | 12 | $61.75 | $803 |
By year: 2022 $40K for 1,087 services; 2023 $74K for 1,264 services; 2024 $23K for 1,767 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jay M Kashkin prescribed most often to Medicare patients was Montelukast Sodium, with 95 prescriptions and refills. In total Jay M Kashkin wrote 467 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 95 | 229 | 23 | $1,393 |
| Takhzyro Lanadelumab-Flyo | 58 | 58 | Under 11 | $2.9M |
| Arnuity Ellipta Fluticasone Furoate | 34 | 50 | Under 11 | $11K |
| Prednisone Generic | 26 | 34 | 14 | $100 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 24 | 25 | 18 | $665 |
| Breo Ellipta Fluticasone/Vilanterol | 22 | 22 | Under 11 | $8,505 |
| Ruconest C1 Esterase Inhibitor, Recomb | 22 | 22 | Under 11 | $1.2M |
| Sajazir Icatibant Acetate | 18 | 18 | Under 11 | $451K |
| Dupixent Syringe Dupilumab | 13 | 13 | Under 11 | $48K |
Brand drugs: 217 claims; generic drugs: 250 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jay M Kashkin $48K ($48K in general payments such as food, travel and fees) from 12 companies. The largest payer was Pharming Healthcare, Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Pharming Healthcare, Inc. | 24 | $12K |
| CSL Behring CSL.AX | 12 | $11K |
| Ionis Pharmaceuticals, Inc. IONS | 16 | $9,999 |
| BioCryst US Sales Co., LLC | 11 | $9,841 |
| BioCryst Pharmaceuticals, Inc. BCRX | 7 | $4,644 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $412 |
| Genzyme Corporation SNY | 15 | $191 |
| Organon LLC OGN | 2 | $29.72 |
| Blueprint Medicines Corporation SNY | 1 | $18.85 |
| Cycle Pharmaceuticals Inc | 1 | $16.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.